INTERCEPT PHARMAC.DL-,001

INTERCEPT PHARMAC.DL-,001 is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. The company's lead product is Ocaliva (obeticholic acid). Intercept Pharmaceuticals is headquartered… Who owns INTERCEPT PHARMAC.DL-,001?…

INTERCEPT PHARMAC.DL-,001 is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. The company's lead product is Ocaliva (obeticholic acid). Intercept Pharmaceuticals is headquartered…

Canonical: https://longshort.io/ticker/I4P.BE